Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
# Objectives To evaluate the total and outpatient economic burden of aspergillosis, and to describe the outpatient antifungal treatment of aspergillosis within a large, commercially-insured population in the United States. # Methods Adults with at least one medical claim with an aspergillosis diagn...
Saved in:
| Main Authors: | Emily Durden, Donna McMorrow, Paul Juneau, Robert Fowler, Paresh Chaudhari, David Horn |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2013-10-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/9862 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis
by: Takahiro Takazono, et al.
Published: (2024-12-01) -
Real-World Antifungal Therapy Patterns Across the Continuum of Care in United States Adults with Invasive Aspergillosis
by: Barbara D. Alexander, et al.
Published: (2024-12-01) -
Longitudinal photovoice examination of workplace experiences for Congolese refugee women in the United States
by: Shannon McMorrow, et al.
Published: (2025-06-01) -
Healthcare Costs of Hospitalizations Due to Aspergillosis and 25-Year Trends in Spain, 1997–2021
by: María Rincón Villar, et al.
Published: (2024-10-01) -
Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021-02-01)